Video Experimental Relacionado
Updated: Jul 11, 2026
06:40
Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
Published on: May 22, 2018
Efectos de la insuficiencia cardíaca experimental en la electrofisiología celular y iónica auricular
Circulation
|June 7, 2000
Resumen
La insuficiencia cardíaca congestiva (ICF) altera la electrofisiología auricular al reducir las corrientes iónicas clave y aumentar la corriente del intercambiador de sodio y calcio. Esta remodelación crea un sustrato para la fibrilación auricular (FA), aumentando su duración.
Área de la Ciencia:
- Fisiología cardiovascular fisiología cardiovascular.
- Electrofisiología Cardíaca Electrofisiología cardíaca.
- Investigación de la insuficiencia cardíaca Investigación de la insuficiencia cardíaca.
Sus antecedentes:
- La insuficiencia cardíaca congestiva (ICC) está fuertemente relacionada con la fibrilación auricular (FA).
- El impacto específico de la insuficiencia cardíaca congestiva en la electrofisiología celular auricular sigue siendo en gran medida desconocido.
- Comprender estos cambios es crucial para el manejo de la FA en pacientes con CHF.
Objetivo del estudio:
- Investigar los efectos de la insuficiencia cardíaca congestiva (ICF) experimental en la electrofisiología de los miocitos auriculares.
- Identificar alteraciones específicas de corriente iónica que contribuyen a la FA en el contexto de CHF.
Principales métodos:
- Inducción de la insuficiencia cardíaca congestiva en perros a través del ritmo ventricular (220-240 bpm durante 5 semanas).
- Medición de las propiedades del potencial de acción (PA) y las corrientes iónicas en miocitos auriculares aislados.
- Comparación de parámetros electrofisiológicos entre CHF y grupos de control.
Principales resultados:
- Los miocitos auriculares de perros con ECH exhibieron hipertrofia.
- Se observaron reducciones significativas en la corriente de tipo L Ca2+ (ICa), la corriente de salida transitorio K2+ (Ito) y la corriente de retraso lento del rectificador K2+ (Ks).
- Se observó un aumento en la corriente del intercambiador (NCX) de Na (((+) / Ca (((2+), mientras que otras corrientes se mantuvieron sin cambios.
- La CHF prolongó la duración del potencial de acción auricular a tasas más rápidas y aumentó significativamente la duración media de la AF.
Conclusiones:
- El CHF experimental altera selectivamente la función del canal iónico auricular, disminuyendo el I(to), el I(Ca) y el I(Ks) mientras aumenta la corriente NCX.
- Esta remodelación electrofisiológica en CHF difiere de la observada en la taquicardia auricular.
- Estos cambios inducidos por CHF crean un sustrato propicio para la fibrilación auricular persistente.
Videos de Conceptos Relacionados
01:19Electrophysiology of Normal Cardiac Rhythm
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...